| |
The Experts in Animal Health |
|
|
|
|
|
|
|
|
|
Brakke
Consulting
2025 Cancer in Dogs and Cats – now available
|
|
Did you
know that cancer is the #1 cause of death in adult dogs? It’s also a leading health concern of dog owners. So
how is cancer addressed by the veterinary profession, and what kind of market
is there for veterinary cancer therapies?
|
|
|
|
Brakke
Consulting’s new 2025
Cancer in Dogs and Cats report includes information on the
incidence, diagnosis, and treatment of the common veterinary cancers. It
covers currently approved veterinary therapies and those in development, as
well as estimates of the numbers of pets treated.
The study
includes a survey of 310 general veterinary practitioners about incidence of
cancer and frequency of treatment; as well as a survey of 1,000 pet owners to
determine what they are willing to pay to treat a pet with cancer.
The
report is available for $8,500. For more information, please contact Dr. Lynn
Fondon at info@brakkeconsulting.com.
|
|
|
|
Company Earnings Releases - Chewy, Inc. released its
financial results for the fiscal year 2024 ended February 2, 2025. Net sales
were $11.86 billion, a 6% increase year over year. Net income was $393 million,
compared to net income of $40 million in the prior year. (company press release)
- Petco Health and
Wellness Company,
Inc. announced its full year 2024 financial results. Net revenue was $6.1
billion, a decrease of 2% year-over-year inclusive of the negative impact from
the loss of the 53rd week in 2023. Comparable sales increased 0.3% year-over-year. GAAP net loss was $(101.8) million compared
to GAAP net loss of $(1.3) billion last year, inclusive of a $1.2 billion
non-cash goodwill impairment charge. (seekingalpha)
- Smithfield Foods reported results for
the full year 2024. Net sales were $14.1 billion, a year-over-year decline of
3%. Operating profit was $1.1 billion compared to an operating loss of $(56)
million in the prior year. (company press release)
- JBS reported earnings for
the full year 2024. Revenue was R$417.0 billion ($72.5 billion), up 15% from
2023. Net income was R$9.62 billion ($1.7 billion), compared to a net loss of
R$(1.06) billions in 2023. (simplywall.st)
|
|
|
|
Company News Releases - The
Human Animal Bond Research Institute (HABRI)
and Freshpet, a fresh pet food
brand, have announced a partnership to advance their shared goal of
strengthening the human-animal bond through research, education and advocacy. (Petfood Industry)
- Privo
Technologies Inc., announced the launch of BeneVet
Oncology, a new subsidiary dedicated to improving the health and well-being
of companion animals. BeneVet will adapt Privo's advanced platforms, originally
developed for human medicine, to enhance therapeutic options for animals. Initial
research and development efforts will focus on cutaneous and subcutaneous solid
tumors. (prnewswire)
- Loyal and the Senior Dog
Veterinary Society announced they have joined forces to support veterinarians
in providing care to senior canine patients.
(company press release)
- PMGC
Holdings Inc.'s wholly owned subsidiary,
NorthStrive Biosciences Inc.
announced an amendment to an existing License Agreement with Korean
biotechnology company MOA Life Plus
Co., Ltd. The Amendment expands the scope of Northstrive Biosciences’ license
rights to all uses of EL-32 and EL-22 in animal health, including all
applications as a feed additive. EL-22 leverages an engineered probiotic
approach to address preserving muscle while patients are on weight loss
treatments. (Globenewswire)
- Australian
telehealth veterinary service Dial A Vet
announced its expansion into Canada, the USA, and the UK. Priced at C$49,
US$35, and GBP 30 per consultation, the rollout offers pet owners 24/7 access
to Australian veterinarians for guidance on pet health, behavior, and
preventative care. (morningstar.com)
- Viticus Group, provider of the
annual Western Veterinary Conference, announced its expansion to Nashville, Tennessee.
The expansion includes WVC Nashville, a new veterinary continuing education
conference, and a state-of- the-art hands-on education center. The inaugural
WVC Nashville event is scheduled for summer 2026. (goodnewsforpets.com)
- AUSTRALIA Elanco
announced that Zolvix Plus (monepantel and abamectin) – a broad spectrum
drench used in the sheep industry – is now registered for use in beef and
non-lactating dairy cattle in Australia. Monepantel belongs to the
amino-acetonitrile derivative family of anthelmintics, the first new broad
spectrum drench class to be registered for use in cattle in Australia for
nearly 40 years. (beefcentral.com)
- UK Swedencare
AB announced it has acquired 100% of the shares in UK-based Summit Veterinary Pharmaceuticals
Limited. Summit develops, produces, and
sells animal health products for veterinary professionals in the UK and Hong
Kong; and had annual revenues of GBP 7.3 million for 2024 calendar year. The
initial purchase price is GBP 30 million ($39 million) along with a two-year
earn-out arrangement. (marketscreener.com)
- SPAIN PAI
Partners announced its agreement to acquire Nuzoa, a distributor of animal health products and services in
Iberia, from Abac Capital. Financial
terms were not disclosed. (company press
release)
- CANADA CowManager
announced the launch of Youngstock Monitor to producers in Canada.
Youngstock Monitor is a new comprehensive solution to monitor calf behavior,
providing real-time health alerts for early disease detection. (company press release)
|
|
|
|
Animal Health Stock Price Tracker |
|
|
|
|
|
Animal Health News - UK - AVIAN INFLUENZA The UK’s Chief Veterinary Officer has
confirmed a case of influenza of avian origin (H5N1) in a single sheep in
Yorkshire following repeat positive milk testing. The case was identified following routine
surveillance of co-located livestock on a premises where avian influenza had
been confirmed in captive birds. This is the first time this virus has been
reported in a sheep. (gov.uk)
- US - TELEMEDICINE A new bill introduced in Michigan’s House
seeks to expand access to veterinary care through telemedicine. House Bill 4200
would allow licensed veterinarians to offer remote consultations under specific
conditions: telemedicine visits would be allowed only after a
veterinarian-client-patient relationship (VCPR) has been established through an
in-person exam and client consent, and could also be used in emergencies. (Vet Candy)
- US - PET CARE
The bipartisan People and Animals Well-being (PAW) Act, has been
reintroduced in Congress, aiming to expand pet insurance access by making
veterinary expenses eligible under Health Savings Accounts (HSAs) and Flexible
Spending Accounts (FSAs). The bill allows pet owners to use up to $1,000 from
these accounts for veterinary care or pet insurance while ensuring unlimited
funds for service animals. (Veterinary Practice News)
|
|
|
|
Brakke Consulting Viewpoint
In
last week’s viewpoint, Lynn Fondon discussed how the veterinarian profession
needs to look beyond price and fee increases to maintain revenue growth. I totally agree. Volume increases is critical to drive
growth. This not only holds true for
veterinarians but also for animal health companies.
First
quarter earnings reports are right around the corner. With visits
to veterinary clinics continuing to decline it will be interesting to
see how 1Q25 revenues will be impacted.
Those companies riding a wave of innovation in the companion animal
business including Zoetis and Elanco may fare better than companies with aging
product lines.
The
latest wave of innovation fueling growth in companion animals is also geared
toward driving patients back to the clinic for treatment, especially for
monoclonal antibodies to address pain and dermatological conditions along with
injectable parasiticides (expected in the next 12-18 months in the US). And we will not be surprised to see livestock
perform well this year.
In
the long run, volume growth is more important than raising prices because it
drives sustainable revenue and market share gains – and it also has an impact
on margin expansion. While raising
prices has a significant and short-term impact on profitability, companies run
the risk of a strong competitive response, of having weak commercial
capabilities to support higher prices or of having customers decide not to
purchase.
Randy Freides
|
|
|
|
Your View
Last week, we asked if you felt it is time for the US to begin
vaccinating poultry against avian influenza.
83% of you said yes.
This week
To
celebrate the publication of our Cancer in Dogs and Cats report, we will share
a tidbit from the report’s pet owner survey.
But first, let’s see if you can guess; we’ll let you know the answer
next week. |
|
What percentage of pet owners say that they would definitely be willing and able to spend more than $10,000 to treat their pet’s cancer? |
|
|
|
|
|
Trouble
viewing this newsletter? You can view it online at www.BrakkeConsulting.com
This
electronic newsletter is the sole property of Brakke Consulting.
Any use of the contents herein should be approved by and appropriately
attributed to Brakke Consulting.
For more information about Brakke Consulting's services and
syndicated studies, visit our website at www.brakkeconsulting.com.
Brakke
Consulting
806
Green Valley Rd
Suite 200
Greensboro, NC 27408 |
|
|
|
|
|
|
.jpg)
